ArticleJournal of Taibah University Medical Sciences2026
High-flow nasal cannula therapy in pediatric care: A regional practice survey from KSA.
Article in Journal of Taibah University Medical Sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To describe current practices related to high-flow nasal cannula (HFNC) therapy among respiratory therapists (RTs) working in pediatric settings across the western region of KSA, specifically in the cities of Almadinah Almunawwarah, Jeddah, and Makkah. Methods: Between January and April 2025, a cross-sectional survey was distributed online to RTs working in pediatric inpatient units in the three cities. The validated questionnaire collected data regarding demographics, hospital characteristics, HFNC initiation practices, adjustment methods, assessment routines, and aerosol delivery practices. Results: In total, 102 RTs from 10 government hospitals participated in the study, where 51.9% worked in standalone children's hospitals. HFNC was most commonly initiated for pneumonia (79.4%) and bronchiolitis (73.5%). Definitions of HFNC varied where 65% of respondents described it as heated gas delivered at a flow rate equal to or exceeding the patient's inspiratory demand. Initial settings were determined based on patient weight (44.1%), therapist-driven protocols (38.2%), or age (9.8%). When oxygenation was suboptimal, 73.5% of RTs increased the FiO Conclusion: HFNC is commonly used in pediatric care across the western region of KSA. However, our results emphasize the need to establish national guidelines or protocols for pediatric HFNC therapy to ensure standardized care and efficient resource utilization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.